• The Super Probiotic. Health Hunters, Newsletter. 27, 1, 2013.
• Probiotics as an alternative strategy for prevention and treatment of human diseases: a review. S. Khani, et al. Inflamm. Allergy Drug Targets, 11(2): 79-89, 2012.
• Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. V. Pala, et al. International Journal of Cancer, 129(11):2712-19, 2011.
• Macrophages of the mucosa-associated lymphoid tissue (MALT) as key elements of the immune response to vitamin D binding protein-macrophage activating factor. S. Pacini, et al. Italian Journal of Anatomy and Embriology, 2014.
• Glycosylated oleic acid/vitamin D-binding protein suppresses Her2 oncogene expression in human breast cancer. M. Ruggiero, et al. Anticancer Research, Sithonia, Grecia, 6-10 Ottobre 2014.
• Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes. K. Maalouf, et al. Cancer Mang Res, 14(3): 39-47, 2011.
• Glycosylated oleic acid/vitamin D-binding protein suppresses Her2 oncogene expression in human breast cancer. M. Ruggiero, et al. Anticancer Research, Sithonia, Grecia, 6-10 Ottobre 2014.
• Clinical experience of immunotherapy based on oleic acid bound to glycosylated vitamin D- binding protein in localised and metastatic adenocarcinoma of the pancreas. L. Thyer, et al. Anticancer Research, Sithonia, Grecia, 6-10 Ottobre 2014.
• Focussed transcranial ultarsounds: application to the delivery of glycosylated oleic acid/vitamin D-binding protein to brain tumours and metastases. J.J.V. Branca, et al. Anticancer Research, Sithonia, Grecia, 6-10 Ottobre 2014.
• Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. I. Wlmadfa, et al. Proc Nutr Soc, 69(3): 416-20, 2010.
• Clinical experience of cancer immunotherapy integrated with oleic acid complexed with de- glycosylated vitamin D binding protein. E.Ward, et al. American Journal of Immunology 10 (1): 23-32, 2014.
• The application of probiotic fermented milks in cancer and intestinal inflammation. A. de Moreno de Leblanc, et al. Proc Nutr Soc, 69(3): 421-8, 2010.
• Clinical experience of renal carcinoma immunotherapy with oleic acid complexed with de- glycosylated vitamin D binding protein. S. Aterini, et al. 55° Congresso Nazionale Società Italiana Nefrologia. Catania, 8-11 Ottobre 2014.
• Oleic acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer. M. Ruggiero, E. Ward, et al. Anticancer Research, 34: 3569-3578, 2014.
• Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. J.R. Lakritz, et al. International Journal of Cancer, 135(3): 529-40, 2014.
• Gc-protein-derived macrophage activating factor (GcMAF) induces ERBB2 shift in human breast cancer. M. Ruggiero, et al. Società Italiana di Anatomia e Istologia, Ancona, Settembre 2014.
• Intra-tumoural nitric oxide release by macrophages activated by Gc-protein-derived macrophage activating factor (GcMAF). M. Ruggiero, et al. Società Italiana di Anatomia e Istologia, Ancona, Settembre 2014.
• Clinical experience of integrative immunotherapy centred on olei acid complexed with de- glycosylated vitamin D binding protein. E. Ward, et al. IX National Conference of the Italian Society of Immunology, Clinical Immunology and Allergology. Firenze, 28-31 Maggio 2014.
• Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. H. Maroof, et al. Journal of Clinical Immunology, 32(6): 1353-9, 2012.
• Increased splenic blood flow following macrophage activation by oleic acid complexed with de-glycosylated vitamin D binding protein. E.Ward, et al. IX National Conference of the Italian Society of Immunology, Clinical Immunology and Allergology. Firenze, 28-31 Maggio 2014.Pu